首页 > 最新文献

Italian journal of gastroenterology and hepatology最新文献

英文 中文
Aging and the gastrointestinal tract. 衰老和胃肠道。
Pub Date : 2003-07-15 DOI: 10.1108/NFS.2004.34.1.48.4
A. Pilotto, P. Malfertheiner, P. Holt
The aim of the present review is to summarize the most recent progress in gastroenterological topics, particularly of the upper gastrointestinal tract, which are of special interest in the elderly. The changes in oesophageal function, particularly disorders of motility, may explain, only in part, the unique clinical characteristics of oesophageal pathologies in the elderly. Dysphagia and gastro-oesophageal reflux disease present diagnostic, clinical and therapeutic characteristics that need to be studied with attention to avoid eventual disability, an impairment of nutritional status and a reduction in the quality of life. Aging, per se, does not significantly modify gastric aggressive factors, however, a selective and specific reduction in some gastric defensive mechanisms seems to occur with aging. The prevention of gastric mucosal injury, particularly that due to drugs, requires a better understanding of these age-related changes. Helicobacter pylori infection in the elderly presents peculiar epidemiological aspects particularly for subjects living in nursing homes. An understanding of Helicobacter pylori-related histological modifications of the gastric mucosa, particularly intestinal metaplasia, gastric atrophy and gastric cancer, the incidence of which seems to be both age- and Helicobacter pylori-related, is greatly needed. Moreover, some diagnostic and therapeutic aspects of Helicobacter pylori infection, i.e., the role of serology and the efficacy, side effects and compliance of drug therapies, are specific for the elderly and require a unique clinical approach. Bleeding is dramatically more frequent in this population. The identification of risk factors, i.e., drugs, pathophysiological mechanisms, i.e., the possible relationship between non-steroidal anti-inflammatory drugs and Helicobacter pylori infection, along with the clinical presentation in the elderly patient, must be the foundation of preventive medical care in geriatric gastroenterology.
本综述的目的是总结胃肠病学的最新进展,特别是上消化道,这是老年人特别感兴趣的。食道功能的改变,特别是运动障碍,可能只能部分解释老年人食道病理的独特临床特征。吞咽困难和胃食管反流病具有诊断、临床和治疗特点,需要注意研究,以避免最终的残疾、营养状况的损害和生活质量的降低。衰老本身并不显著改变胃的侵袭因子,然而,一些胃的防御机制似乎随着年龄的增长而选择性和特异性地减少。预防胃粘膜损伤,特别是药物引起的胃粘膜损伤,需要更好地了解这些与年龄相关的变化。老年人幽门螺杆菌感染表现出特殊的流行病学方面,特别是对生活在养老院的受试者。了解幽门螺杆菌相关的胃粘膜组织学改变,特别是肠化生、胃萎缩和胃癌,其发病率似乎与年龄和幽门螺杆菌相关,是非常必要的。此外,幽门螺杆菌感染的一些诊断和治疗方面,即血清学的作用和药物治疗的疗效、副作用和依从性,是老年人特有的,需要独特的临床方法。出血在这一人群中更为频繁。识别危险因素,即药物、病理生理机制,即非甾体类抗炎药与幽门螺杆菌感染之间的可能关系,以及老年患者的临床表现,必须成为老年胃肠病学预防医疗的基础。
{"title":"Aging and the gastrointestinal tract.","authors":"A. Pilotto, P. Malfertheiner, P. Holt","doi":"10.1108/NFS.2004.34.1.48.4","DOIUrl":"https://doi.org/10.1108/NFS.2004.34.1.48.4","url":null,"abstract":"The aim of the present review is to summarize the most recent progress in gastroenterological topics, particularly of the upper gastrointestinal tract, which are of special interest in the elderly. The changes in oesophageal function, particularly disorders of motility, may explain, only in part, the unique clinical characteristics of oesophageal pathologies in the elderly. Dysphagia and gastro-oesophageal reflux disease present diagnostic, clinical and therapeutic characteristics that need to be studied with attention to avoid eventual disability, an impairment of nutritional status and a reduction in the quality of life. Aging, per se, does not significantly modify gastric aggressive factors, however, a selective and specific reduction in some gastric defensive mechanisms seems to occur with aging. The prevention of gastric mucosal injury, particularly that due to drugs, requires a better understanding of these age-related changes. Helicobacter pylori infection in the elderly presents peculiar epidemiological aspects particularly for subjects living in nursing homes. An understanding of Helicobacter pylori-related histological modifications of the gastric mucosa, particularly intestinal metaplasia, gastric atrophy and gastric cancer, the incidence of which seems to be both age- and Helicobacter pylori-related, is greatly needed. Moreover, some diagnostic and therapeutic aspects of Helicobacter pylori infection, i.e., the role of serology and the efficacy, side effects and compliance of drug therapies, are specific for the elderly and require a unique clinical approach. Bleeding is dramatically more frequent in this population. The identification of risk factors, i.e., drugs, pathophysiological mechanisms, i.e., the possible relationship between non-steroidal anti-inflammatory drugs and Helicobacter pylori infection, along with the clinical presentation in the elderly patient, must be the foundation of preventive medical care in geriatric gastroenterology.","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 2 1","pages":"137-53"},"PeriodicalIF":0.0,"publicationDate":"2003-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"62149798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
Renovascular impedance after total paracentesis. 全穿刺后肾血管阻抗。
A Colli, M Cocciolo, M Fraquelli, D Conte
{"title":"Renovascular impedance after total paracentesis.","authors":"A Colli, M Cocciolo, M Fraquelli, D Conte","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"898"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21523964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echinococcal liver cysts: treatment with echo-guided percutaneous puncture PAIR for echinococcal liver cysts. 棘球蚴性肝囊肿:超声引导下经皮穿刺治疗棘球蚴性肝囊肿。
F G Crippa, R Bruno, E Brunetti, C Filice

In spite of recent progress, treatment for liver echinococcal cysts is still far from satisfying. In recent years, percutaneous drainage has been increasingly used for this purpose and it has been shown to be an effective alternative to surgery and chemotherapy alone. This technique is known as PAIR, from Puncture, Aspiration, Injection (of a scolecidal agent), Reaspiration: here we present our experience and the state of the art of PAIR. Patients from Italy and Turkana (Kenya), harbouring 233 Gharbi type I, II and III echinococcal cysts were successfully treated with PAIR: it was performed according to protocols established at the Division of Infectious and Tropical Diseases, IRCCS--Policlinico S. Matteo, University of Pavia. In Italy, one relapse was recorded, four years after the procedure; the patient was treated again with PAIR; no cases of anaphylactic shock or peritoneal dissemination were observed in a follow-up of 10 years; only 10 minor complications (biliary fistula, urticarioid reaction, abscessualization of the cyst, anaphylactoid reactions) were reported. Long-term results indicate that in Gharbi type I, II and III echinococcal cysts, and in developing countries, in particular, PAIR is a first choice method for the treatment of abdominal localizations of this disease.

尽管最近取得了进展,但肝包虫病囊肿的治疗仍远不能令人满意。近年来,经皮引流越来越多地用于此目的,并且已被证明是单独手术和化疗的有效替代方法。这项技术被称为PAIR,从穿刺,抽吸,注射(一种脊柱侧突剂),呼吸:在这里我们介绍我们的经验和PAIR技术的现状。来自意大利和图尔卡纳(肯尼亚)的233例Gharbi I型、II型和III型包囊的患者成功地接受了PAIR治疗:该治疗是根据帕维亚大学icccs -Policlinico S. Matteo传染病和热带病司制定的方案进行的。在意大利,有一例手术后四年复发的病例;再次给予PAIR治疗;在10年的随访中未发现过敏性休克或腹膜播散病例;仅有10例轻微并发症(胆道瘘、类荨麻疹反应、囊肿脓肿、类过敏反应)被报道。长期结果表明,在Gharbi I型、II型和III型棘球蚴囊肿中,特别是在发展中国家,PAIR是治疗这种疾病腹部局限性的首选方法。
{"title":"Echinococcal liver cysts: treatment with echo-guided percutaneous puncture PAIR for echinococcal liver cysts.","authors":"F G Crippa,&nbsp;R Bruno,&nbsp;E Brunetti,&nbsp;C Filice","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In spite of recent progress, treatment for liver echinococcal cysts is still far from satisfying. In recent years, percutaneous drainage has been increasingly used for this purpose and it has been shown to be an effective alternative to surgery and chemotherapy alone. This technique is known as PAIR, from Puncture, Aspiration, Injection (of a scolecidal agent), Reaspiration: here we present our experience and the state of the art of PAIR. Patients from Italy and Turkana (Kenya), harbouring 233 Gharbi type I, II and III echinococcal cysts were successfully treated with PAIR: it was performed according to protocols established at the Division of Infectious and Tropical Diseases, IRCCS--Policlinico S. Matteo, University of Pavia. In Italy, one relapse was recorded, four years after the procedure; the patient was treated again with PAIR; no cases of anaphylactic shock or peritoneal dissemination were observed in a follow-up of 10 years; only 10 minor complications (biliary fistula, urticarioid reaction, abscessualization of the cyst, anaphylactoid reactions) were reported. Long-term results indicate that in Gharbi type I, II and III echinococcal cysts, and in developing countries, in particular, PAIR is a first choice method for the treatment of abdominal localizations of this disease.</p>","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"884-92"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21523962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative non-surgical management of congenital oesophageal stenosis associated with oesophageal atresia. 先天性食管狭窄合并食管闭锁的保守性非手术治疗。
C Pesce, L Musi, P Campobasso, L Costa, A Mercurella
{"title":"Conservative non-surgical management of congenital oesophageal stenosis associated with oesophageal atresia.","authors":"C Pesce,&nbsp;L Musi,&nbsp;P Campobasso,&nbsp;L Costa,&nbsp;A Mercurella","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"899-900"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21523965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative. 胃癌患者幽门螺杆菌阳性与幽门螺杆菌阴性的鉴别特征。
D Jonkers, P Houben, W Hameeteman, E Stobberingh, A de Bruine, J W Arends, I Biemond, G Lundqvist, R Stockbrügger

Background: Helicobacter pylori infection is associated with an increased risk of gastric cancer. In Helicobacter pylori negative patients, factors different from those in Helicobacter pylori positive patients may be involved in gastric carcinogenesis.

Methods: Thirty-nine recently diagnosed consecutive patients with gastric cancer were investigated. Gastric biopsies were obtained for detection of Helicobacter pylori (by immunohistochemistry), non-Helicobacter pylori flora (by modified Giemsa and culture) and histological assessment according to the Sydney classification by Haematoxylin-Eosin staining. In serum samples, Helicobacter pylori antibodies were determined by IgG enzyme-linked immunosorbent assay, IgA enzyme-linked immunosorbent assay, and Western blotting. Furthermore, serum gastrin, pepsinogen A and C and plasma chromogranin A were determined.

Results: Helicobacter pylori was detected by immunohistochemistry in 53.8%, by IgG in 56.4%, by IgA in 33.3%, and by Western blotting in 74.4% of the 39 patients. Ten patients (25.6%) were negative by both histology and serology. Non-Helicobacter pylori flora was detected in 27 of the 39 patients (69.2%) with a similar frequency in Helicobacter pylori positive and negative patients. Helicobacter pylori positivity was found significantly more often in diffuse than intestinal type carcinoma patients (p < 0.05). Elevated gastrin levels and antrum-sparing atrophic gastritis were more frequent in Helicobacter pylori negative than in Helicobacter pylori positive patients (p < 0.05).

Conclusions: In 10 out of 39 gastric cancer patients, no evidence of previous or current Helicobacter pylori infection could be demonstrated. Non-Helicobacter pylori was found in 69.2% of patients regardless of the Helicobacter pylori status. Further studies are needed to establish the contribution of non-Helicobacter pylori flora as well as antrum-sparing atrophic gastritis with hypergastrinaemia to the development of gastric cancer.

背景:幽门螺杆菌感染与胃癌风险增加有关。在幽门螺杆菌阴性患者中,与幽门螺杆菌阳性患者不同的因素可能参与胃癌的发生。方法:对39例新近确诊的连续胃癌患者进行调查。行胃活检,检测幽门螺杆菌(免疫组化法)、非幽门螺杆菌菌群(改良吉姆萨法和培养法),并采用haematoxylineosin染色法按Sydney分类进行组织学评估。血清样品采用IgG酶联免疫吸附法、IgA酶联免疫吸附法和Western blotting检测幽门螺杆菌抗体。测定血清胃泌素、胃蛋白酶原A、C和血浆嗜铬粒蛋白A。结果:39例患者免疫组化检出幽门螺杆菌53.8%,IgG 56.4%, IgA 33.3%,免疫印迹检测74.4%。10例(25.6%)患者病理及血清学均为阴性。39例患者中有27例(69.2%)检出非幽门螺杆菌菌群,在幽门螺杆菌阳性和阴性患者中检出率相似。弥漫性胃癌幽门螺杆菌阳性明显高于肠型癌(p < 0.05)。幽门螺杆菌阴性患者胃泌素水平升高和保留胃窦的萎缩性胃炎发生率高于幽门螺杆菌阳性患者(p < 0.05)。结论:39例胃癌患者中有10例既往或目前未发现幽门螺杆菌感染的证据。无论是否存在幽门螺杆菌,69.2%的患者均未发现幽门螺杆菌。非幽门螺杆菌菌群以及保留胃窦的萎缩性胃炎伴高胃酸血症在胃癌发展中的作用有待进一步研究。
{"title":"Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.","authors":"D Jonkers,&nbsp;P Houben,&nbsp;W Hameeteman,&nbsp;E Stobberingh,&nbsp;A de Bruine,&nbsp;J W Arends,&nbsp;I Biemond,&nbsp;G Lundqvist,&nbsp;R Stockbrügger","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori infection is associated with an increased risk of gastric cancer. In Helicobacter pylori negative patients, factors different from those in Helicobacter pylori positive patients may be involved in gastric carcinogenesis.</p><p><strong>Methods: </strong>Thirty-nine recently diagnosed consecutive patients with gastric cancer were investigated. Gastric biopsies were obtained for detection of Helicobacter pylori (by immunohistochemistry), non-Helicobacter pylori flora (by modified Giemsa and culture) and histological assessment according to the Sydney classification by Haematoxylin-Eosin staining. In serum samples, Helicobacter pylori antibodies were determined by IgG enzyme-linked immunosorbent assay, IgA enzyme-linked immunosorbent assay, and Western blotting. Furthermore, serum gastrin, pepsinogen A and C and plasma chromogranin A were determined.</p><p><strong>Results: </strong>Helicobacter pylori was detected by immunohistochemistry in 53.8%, by IgG in 56.4%, by IgA in 33.3%, and by Western blotting in 74.4% of the 39 patients. Ten patients (25.6%) were negative by both histology and serology. Non-Helicobacter pylori flora was detected in 27 of the 39 patients (69.2%) with a similar frequency in Helicobacter pylori positive and negative patients. Helicobacter pylori positivity was found significantly more often in diffuse than intestinal type carcinoma patients (p < 0.05). Elevated gastrin levels and antrum-sparing atrophic gastritis were more frequent in Helicobacter pylori negative than in Helicobacter pylori positive patients (p < 0.05).</p><p><strong>Conclusions: </strong>In 10 out of 39 gastric cancer patients, no evidence of previous or current Helicobacter pylori infection could be demonstrated. Non-Helicobacter pylori was found in 69.2% of patients regardless of the Helicobacter pylori status. Further studies are needed to establish the contribution of non-Helicobacter pylori flora as well as antrum-sparing atrophic gastritis with hypergastrinaemia to the development of gastric cancer.</p>","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"836-41"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21524051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is autoimmunity involved in the relationship between Helicobacter pylori infection, atrophic gastritis and gastric cancer? 幽门螺杆菌感染与萎缩性胃炎、胃癌之间的关系是否与自身免疫有关?
R Negrini
{"title":"Is autoimmunity involved in the relationship between Helicobacter pylori infection, atrophic gastritis and gastric cancer?","authors":"R Negrini","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"842-5"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21524052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders. 循环中的促抗氧化因子铁和卟啉代谢紊乱。
E Rocchi, G Casalgrandi, A Masini, F Giovannini, D Ceccarelli, M Ferrali, S Marchini, E Ventura

Background: Porphyria cutanea tarda and haemochromatosis are taken to be spontaneous human models of oxidative cellular damage, with an increased risk of fibrosis and cancer evolution.

Aim: To define the relative pro-oxidant roles of porphyrin and iron, in their different molecular forms, and their effects on antioxidant biological systems.

Patients: A group of 17 patients with porphyria cutanea tarda and a group of 14 patients with primary and secondary haemochromatosis, were compared with 21 healthy controls.

Methods: Plasma retinol, tocopherol, alpha- and beta-carotene, ascorbic acid, glutathione, malonyldialdehyde and red blood cell free iron were determined using high performance liquid chromatography.

Results: Only a modest increase in iron stores was demonstrated in the porphyria cutanea tarda group; in the haemochromatosis patients ferritin levels were almost seven times higher. By contrast, there was a sharp and virtually identical increase in red blood cell free iron and malonyldialdehyde in both the patient groups. A significant reduction was observed in retinol, alpha-, beta-carotene and red blood cell glutathione levels being more marked in porphyria cutanea tarda than in haemochromatosis patients.

Conclusions: The study confirms the strong pro-oxidant effects of porphyrins in vivo, through an induction of the free toxic iron form, even though the total iron pool is not greatly expanded. The additional free-iron and porphyrin oxidant effects are documented both in red blood cell and plasma in the porphyria cutanea tarda group. It confirmed that aging exerts a negative influence in terms of pro- and antioxidant balance in all cases, but particularly in the haemochromatosis group.

背景:迟发性皮肤卟啉症和血色素沉着症被认为是自发的人类氧化细胞损伤模型,具有纤维化和癌症发展的风险增加。目的:明确不同分子形式的卟啉和铁的相对促氧化作用及其对抗氧化生物系统的影响。患者:将17例迟发性皮肤卟啉症患者和14例原发性和继发性血色病患者与21例健康对照进行比较。方法:采用高效液相色谱法测定血浆视黄醇、生育酚、α -胡萝卜素和β -胡萝卜素、抗坏血酸、谷胱甘肽、丙二醛和红细胞游离铁。结果:迟发性皮肤卟啉组铁储量仅略有增加;血色素沉着病患者的铁蛋白水平几乎高出7倍。相比之下,在两组患者中,红细胞游离铁和丙二醛的急剧增加几乎相同。观察到视黄醇、α -、β -胡萝卜素和红细胞谷胱甘肽水平的显著降低,在迟发性皮肤卟啉症患者中比在血色素沉着症患者中更为明显。结论:该研究证实了卟啉在体内的强促氧化作用,通过诱导游离的有毒铁形式,即使总铁池没有大大扩大。在迟发性皮肤卟啉组的红细胞和血浆中均记录了额外的游离铁和卟啉氧化作用。研究证实,在所有情况下,衰老对促氧化剂和抗氧化剂的平衡都有负面影响,但在血色素沉着症组中尤其如此。
{"title":"Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders.","authors":"E Rocchi,&nbsp;G Casalgrandi,&nbsp;A Masini,&nbsp;F Giovannini,&nbsp;D Ceccarelli,&nbsp;M Ferrali,&nbsp;S Marchini,&nbsp;E Ventura","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Porphyria cutanea tarda and haemochromatosis are taken to be spontaneous human models of oxidative cellular damage, with an increased risk of fibrosis and cancer evolution.</p><p><strong>Aim: </strong>To define the relative pro-oxidant roles of porphyrin and iron, in their different molecular forms, and their effects on antioxidant biological systems.</p><p><strong>Patients: </strong>A group of 17 patients with porphyria cutanea tarda and a group of 14 patients with primary and secondary haemochromatosis, were compared with 21 healthy controls.</p><p><strong>Methods: </strong>Plasma retinol, tocopherol, alpha- and beta-carotene, ascorbic acid, glutathione, malonyldialdehyde and red blood cell free iron were determined using high performance liquid chromatography.</p><p><strong>Results: </strong>Only a modest increase in iron stores was demonstrated in the porphyria cutanea tarda group; in the haemochromatosis patients ferritin levels were almost seven times higher. By contrast, there was a sharp and virtually identical increase in red blood cell free iron and malonyldialdehyde in both the patient groups. A significant reduction was observed in retinol, alpha-, beta-carotene and red blood cell glutathione levels being more marked in porphyria cutanea tarda than in haemochromatosis patients.</p><p><strong>Conclusions: </strong>The study confirms the strong pro-oxidant effects of porphyrins in vivo, through an induction of the free toxic iron form, even though the total iron pool is not greatly expanded. The additional free-iron and porphyrin oxidant effects are documented both in red blood cell and plasma in the porphyria cutanea tarda group. It confirmed that aging exerts a negative influence in terms of pro- and antioxidant balance in all cases, but particularly in the haemochromatosis group.</p>","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"861-7"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21524055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia. 以往的内镜治疗不影响腹腔镜下Heller肌切开术和前底折叠治疗食管贲门失弛缓症的并发症发生率和结果。
L Bonavina, R Incarbone, L Antoniazzi, M Reitano, A Peracchia

Background: Anedoctal reports suggest a detrimental effect of pneumatic dilation and botulinum toxin injection in patients who are potential candidates for Heller myotomy.

Aims: To assess symptomatic and objective outcome in patients undergoing Heller myotomy as a primary procedure or after failed endoscopic treatment.

Patients: Between November 1992 and December 1998, 92 patients with oesophageal achalasia were treated. Sixty patients had primary surgery; 32 patients had surgery after unsuccessful pneumatic dilation (n = 22), or botulinum toxin injection (n = 10).

Methods: Laparoscopic Heller myotomy plus Dor fundoplication with routine intraoperative endoscopy. Operative records, symptoms, and results of radiological, manometric and scintigraphic assessment in the two groups of patients were compared.

Results: The mean operative time, the rate of intraoperative mucosal tears and the incidence of postoperative dysphagia were similar in the two groups. Mucosal tears occurred more frequently during the first 30 operations (p < 0.05). Median follow-up was 28 months (range 4-76). An abnormal oesophageal acid exposure was documented in 2 patients in the primary surgery group (7.7%), and in 2 patients in the pneumatic dilation/botulinum toxin group (13.3%) (p = ns). Lower oesophageal sphincter pressure significantly decreased in both groups (p < 0.01). The mean percentage of radionuclide residual activity in the oesophagus at 1 and 10 minutes significantly decreased in both groups (p < 0.01).

Conclusions: There was only a trend, although not statistically significant, towards an increased risk of complications and adverse effects in patients previously treated by pneumatic dilation or botulinum toxin. The higher incidence of mucosal tears during the first 30 operations suggests the effect of the learning curve.

背景:内科报告显示,对于可能需要进行海勒肌切开术的患者,气动扩张和肉毒杆菌毒素注射是有害的。目的:评估以海勒肌切开术为主要手术或内镜治疗失败的患者的症状和客观结果。患者:1992年11月至1998年12月,对92例食道失弛缓症患者进行了治疗。60例患者进行了初次手术;32例患者在充气扩张失败(22例)或注射肉毒杆菌毒素(10例)后进行手术。方法:腹腔镜下Heller肌切开术加术中常规内镜下Dor底叠术。比较两组患者的手术记录、症状以及放射学、血压计和影像学评估结果。结果:两组患者的平均手术时间、术中粘膜撕裂率及术后吞咽困难发生率无明显差异。前30次手术中粘膜撕裂发生率较高(p < 0.05)。中位随访时间为28个月(范围4-76)。原发性手术组2例(7.7%)出现食管酸暴露异常,气压扩张/肉毒杆菌毒素组2例(13.3%)出现异常(p = ns)。两组患者食管下括约肌压力均显著降低(p < 0.01)。两组患者1、10分钟食道内平均放射性核素残留活性百分比均显著降低(p < 0.01)。结论:虽然没有统计学意义,但只有一种趋势,即以前接受过气动扩张或肉毒杆菌毒素治疗的患者并发症和不良反应的风险增加。前30次手术中较高的粘膜撕裂发生率提示了学习曲线的作用。
{"title":"Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia.","authors":"L Bonavina,&nbsp;R Incarbone,&nbsp;L Antoniazzi,&nbsp;M Reitano,&nbsp;A Peracchia","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Anedoctal reports suggest a detrimental effect of pneumatic dilation and botulinum toxin injection in patients who are potential candidates for Heller myotomy.</p><p><strong>Aims: </strong>To assess symptomatic and objective outcome in patients undergoing Heller myotomy as a primary procedure or after failed endoscopic treatment.</p><p><strong>Patients: </strong>Between November 1992 and December 1998, 92 patients with oesophageal achalasia were treated. Sixty patients had primary surgery; 32 patients had surgery after unsuccessful pneumatic dilation (n = 22), or botulinum toxin injection (n = 10).</p><p><strong>Methods: </strong>Laparoscopic Heller myotomy plus Dor fundoplication with routine intraoperative endoscopy. Operative records, symptoms, and results of radiological, manometric and scintigraphic assessment in the two groups of patients were compared.</p><p><strong>Results: </strong>The mean operative time, the rate of intraoperative mucosal tears and the incidence of postoperative dysphagia were similar in the two groups. Mucosal tears occurred more frequently during the first 30 operations (p < 0.05). Median follow-up was 28 months (range 4-76). An abnormal oesophageal acid exposure was documented in 2 patients in the primary surgery group (7.7%), and in 2 patients in the pneumatic dilation/botulinum toxin group (13.3%) (p = ns). Lower oesophageal sphincter pressure significantly decreased in both groups (p < 0.01). The mean percentage of radionuclide residual activity in the oesophagus at 1 and 10 minutes significantly decreased in both groups (p < 0.01).</p><p><strong>Conclusions: </strong>There was only a trend, although not statistically significant, towards an increased risk of complications and adverse effects in patients previously treated by pneumatic dilation or botulinum toxin. The higher incidence of mucosal tears during the first 30 operations suggests the effect of the learning curve.</p>","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"827-30"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21523533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macroamylase detection in serum using selective precipitation: a rapid and reliable assay. 选择性沉淀法检测血清中巨淀粉酶:一种快速可靠的方法。
M Ventrucci, A Cipolla, M Middonno, C Racchini, E Pollini, G V Melzi d'Eril

Background and aim: Available assays for measurement of pancreatic isoamylase in serum based on specific immunoinhibition of salivary fraction are unable to detect macroamylase. We combined a polyethylene glycol test which identifies macroamylase by selective precipitation with an automated assay for total amylase and pancreatic isoamylase measurement.

Methods: We analysed 24 sera proven positive for macroamylase using gel filtration chromatography and 80 negative sera. Precipitation of macroamylase with polyethylene glycol, colourimetric measurement of total amylase activity and immunoinhibition for the determination of pancreatic isoamylase were carried out.

Results: Macroamylasaemic sera showed precipitation of at least 71% of the amylase activity, while sera with normal-sized amylase exhibited a maximum of 61%. In all the macroamylasaemic sera but two, the immunoinhibition test showed a rise in pancreatic isoamylase, which was found to be the prevalent fraction in 16. In 21 out of 24 sera with macroamylase and 67 out of 80 with normal-sized amylase, the precipitated amylase activity was also measured after immunoinhibition of non pancreatic activity. In macroamylasaemic sera, the percentage of precipitated pancreatic isoamylase activity ranged from 75% to 98%, while in samples with normal-sized amylase it was less than 71%.

Conclusions: Polyethylene glycol precipitation can easily be combined with automated assays for the determination of pancreatic isoamylase and should be carried out whenever dealing with hyperamylasaemia of unclear origin.

背景和目的:现有的基于唾液部分特异性免疫抑制的血清胰腺异淀粉酶测定方法无法检测巨淀粉酶。我们结合了聚乙二醇测试,通过选择性沉淀识别大淀粉酶与总淀粉酶和胰腺异淀粉酶的自动测定。方法:采用凝胶过滤层析法对24例大淀粉酶阳性血清和80例大淀粉酶阴性血清进行分析。用聚乙二醇沉淀大淀粉酶,用比色法测定总淀粉酶活性,用免疫抑制法测定胰腺异淀粉酶。结果:大淀粉酶血症血清显示至少71%的淀粉酶活性沉淀,而正常大小的淀粉酶血清显示最多61%。在所有的大淀粉酶血症血清中,除两种外,免疫抑制试验显示胰腺异淀粉酶升高,这是16年发现的普遍部分。在24份含有大淀粉酶的血清中有21份和80份含有正常大小淀粉酶的血清中有67份,在免疫抑制非胰腺活性后也测量了沉淀淀粉酶的活性。在大淀粉酶血症的血清中,胰腺异淀粉酶活性的沉淀百分比在75%到98%之间,而在正常淀粉酶的样本中,这一比例不到71%。结论:聚乙二醇沉淀法可方便地与自动测定法联合用于胰腺异淀粉酶的测定,在处理来历不明的高淀粉酶血症时应采用聚乙二醇沉淀法。
{"title":"Macroamylase detection in serum using selective precipitation: a rapid and reliable assay.","authors":"M Ventrucci,&nbsp;A Cipolla,&nbsp;M Middonno,&nbsp;C Racchini,&nbsp;E Pollini,&nbsp;G V Melzi d'Eril","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background and aim: </strong>Available assays for measurement of pancreatic isoamylase in serum based on specific immunoinhibition of salivary fraction are unable to detect macroamylase. We combined a polyethylene glycol test which identifies macroamylase by selective precipitation with an automated assay for total amylase and pancreatic isoamylase measurement.</p><p><strong>Methods: </strong>We analysed 24 sera proven positive for macroamylase using gel filtration chromatography and 80 negative sera. Precipitation of macroamylase with polyethylene glycol, colourimetric measurement of total amylase activity and immunoinhibition for the determination of pancreatic isoamylase were carried out.</p><p><strong>Results: </strong>Macroamylasaemic sera showed precipitation of at least 71% of the amylase activity, while sera with normal-sized amylase exhibited a maximum of 61%. In all the macroamylasaemic sera but two, the immunoinhibition test showed a rise in pancreatic isoamylase, which was found to be the prevalent fraction in 16. In 21 out of 24 sera with macroamylase and 67 out of 80 with normal-sized amylase, the precipitated amylase activity was also measured after immunoinhibition of non pancreatic activity. In macroamylasaemic sera, the percentage of precipitated pancreatic isoamylase activity ranged from 75% to 98%, while in samples with normal-sized amylase it was less than 71%.</p><p><strong>Conclusions: </strong>Polyethylene glycol precipitation can easily be combined with automated assays for the determination of pancreatic isoamylase and should be carried out whenever dealing with hyperamylasaemia of unclear origin.</p>","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"846-9"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21524053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small bowel schwannoma with diffuse subcutaneous lipomatosis. Case report and literature review. 小肠神经鞘瘤伴弥漫性皮下脂肪瘤病。病例报告及文献复习。
E Fiori, P L Mingazzini, S E Lutzu, G Galati, M Bononi, A De Cesare, C Provenza, V Cangemi

A case of a small-bowel schwannoma with diffuse familiar lipomatosis is described. This case underlines the rarity of the neoplasm and its probably chance association with subcutaneous lipomatosis. The intestinal neoplasm was diagnosed preoperatively by upper gastrointestinal endoscopy and a small-bowel enema; computed tomography scan confirmed the intestinal lesion. Attention is focused on the morphological features of intestinal schwannomas and their biological behaviour.

本文报告一例小肠神经鞘瘤伴弥漫性熟悉型脂肪瘤病。这个病例强调了肿瘤的罕见性及其可能与皮下脂肪瘤病的偶然关联。术前通过上消化道内镜和小肠灌肠诊断肠道肿瘤;计算机断层扫描证实了肠道病变。关注肠神经鞘瘤的形态学特征及其生物学行为。
{"title":"Small bowel schwannoma with diffuse subcutaneous lipomatosis. Case report and literature review.","authors":"E Fiori,&nbsp;P L Mingazzini,&nbsp;S E Lutzu,&nbsp;G Galati,&nbsp;M Bononi,&nbsp;A De Cesare,&nbsp;C Provenza,&nbsp;V Cangemi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A case of a small-bowel schwannoma with diffuse familiar lipomatosis is described. This case underlines the rarity of the neoplasm and its probably chance association with subcutaneous lipomatosis. The intestinal neoplasm was diagnosed preoperatively by upper gastrointestinal endoscopy and a small-bowel enema; computed tomography scan confirmed the intestinal lesion. Attention is focused on the morphological features of intestinal schwannomas and their biological behaviour.</p>","PeriodicalId":79501,"journal":{"name":"Italian journal of gastroenterology and hepatology","volume":"31 9","pages":"868-71"},"PeriodicalIF":0.0,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21524056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Italian journal of gastroenterology and hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1